Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |